Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit
Express News | Nurix Therapeutics Announces Presentations at the 7TH Annual Tpd & Induced Proximity Summit
Jefferies Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $41
A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $29 to $41
Analysts Are Bullish on Top Healthcare Stocks: Nurix Therapeutics (NRIX), Ascendis Pharma (ASND)
Nurix Therapeutics Analyst Ratings